Plastic particles from surgical masks and water bottles can bind to antibiotics in water, changing their surface properties in measurable ways, which suggests these plastics may transport drugs in the environment.
Claim Context
Microplastics from surgical masks and plastic bottles can sorb antibiotics such as amoxicillin and spiramycin in aqueous environments, altering surface chemistry as evidenced by shifts in FTIR and Raman spectral peaks and changes in O/C and C/N ratios, indicating that consumer-grade plastics may act as carriers for pharmaceutical compounds in environmental systems.
“The sorption results showed that adsorption kinetics and the isotherm of amoxicillin and spiramycin on micro(nano)plastics from surgical masks and plastic bottles closely fit the pseudo-second-order kinetic model and Langmuir isotherm. These results indicated that the evidence for the antibiotic interaction with particles was changes in the surface functional group intensities and up-shifting, and this correlated with the sorption of antibiotics on micro(nano)-sized plastics.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review of all in vitro studies on antibiotic sorption to consumer-grade microplastics could quantify the consistency, magnitude, and polymer-specificity of this interaction across diverse environmental conditions.
A systematic review and meta-analysis of all peer-reviewed in vitro studies (n≥50) examining antibiotic sorption to polypropylene and PET microplastics from masks and bottles, using standardized methods for antibiotic concentration, pH, temperature, and surface characterization, with outcome measures including sorption capacity (qmax), kinetics, and surface index changes.
An RCT cannot be ethically or practically applied to this claim, as it involves non-biological chemical sorption in a test tube, not a biological intervention.
Not applicable — this is a physicochemical interaction, not a biological intervention requiring randomization.
A cohort study could track environmental microplastic samples over time in wastewater or marine systems to determine if antibiotic sorption correlates with antibiotic usage patterns in human populations.
A longitudinal cohort study collecting microplastic particles from wastewater treatment effluent (n=500 samples) across 12 months in 10 cities with varying antibiotic prescription rates, measuring antibiotic concentration and surface chemistry changes via FTIR and EDX, and correlating with local pharmaceutical consumption data.
A case-control study could compare microplastics from high-antibiotic-use environments (e.g., hospitals) versus low-use areas (e.g., remote rivers) to determine if antibiotic sorption is more prevalent in high-exposure settings.
A case-control study comparing microplastics from hospital wastewater (cases, n=100) versus urban river runoff (controls, n=100), measuring antibiotic concentration bound to particles and surface functional group changes, with matching for particle size, polymer type, and sampling season.
A cross-sectional study could measure antibiotic sorption on microplastics collected from diverse environments at a single time point to map geographic variation in this interaction.
A cross-sectional survey collecting microplastic particles (n=300) from 30 diverse locations (urban rivers, oceans, drinking water sources, soil) and measuring bound antibiotic concentrations and surface chemistry changes via FTIR and EDX to identify environmental predictors of sorption.